What it comes down to is that the presentation was not marked as price sensitive, where as this one is. Whose fault is that?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025